Publisher
Springer Science and Business Media LLC
Reference114 articles.
1. Abdollahifard, S. (2022). Intranasal oxytocin in autism spectrum disorder children and adolescents. Clinical Psychiatry, 8(8), 102–103. Available at: https://www.primescholars.com/clinical-psychiatry.html
2. Alsayouf, H. A., Talo, H., Biddappa, M. L., & De Los Reyes, E. (2021). Risperidone or aripiprazole can resolve autism core signs and symptoms in young children: Case Study. Children (Basel), 8(5). https://doi.org/10.3390/children8050318
3. Althaus, M., Groen, Y., Wijers, A. A., Noltes, H., Tucha, O., Sweep, F. C., et al. (2016). Do blood plasma levels of oxytocin moderate the effect of nasally administered oxytocin on social orienting in high-functioning male adults with autism spectrum disorder? Psychopharmacology, 233(14), 2737–2751. https://doi.org/10.1007/s00213-016-4339-1
4. Anagnostou, E., Soorya, L., Brian, J., Dupuis, A., Mankad, D., Smile, S., & Jacob, S. (2014). Intranasal oxytocin in the treatment of autism spectrum disorders: A review of literature and early safety and efficacy data in youth. Brain Research, 1580, 188–198. https://doi.org/10.1016/j.brainres.2014.01.049
5. Anagnostou, E., Soorya, L., Chaplin, W., Bartz, J., Halpern, D., Wasserman, S., et al. (2012). Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: A randomized controlled trial. Molecular Autism, 3(1), 16. https://doi.org/10.1186/2040-2392-3-16
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献